Radiotherapy & Oncology
Volume 89, Issue 2 , Pages 141-149 , November 2008

Abdominal cancer during early childhood: A dosimetric comparison of proton beams to standard and advanced photon radiotherapy

  • Martin Hillbrand

      Affiliations

    • Department of Radiotherapy and Radiobiology, AKH Vienna, Medical University Vienna, Austria
    • Corresponding Author InformationCorresponding author. Martin Hillbrand, Division of Medical Radiation Physics, Department of Radiotherapy and Radiobiology, AKH Vienna, Medical University Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
    • ,
  • Dietmar Georg

      Affiliations

    • Department of Radiotherapy and Radiobiology, AKH Vienna, Medical University Vienna, Austria
    • ,
  • Helmut Gadner

      Affiliations

    • St. Anna Children’s Hospital, Vienna, Austria
    • ,
  • Richard Pötter

      Affiliations

    • Department of Radiotherapy and Radiobiology, AKH Vienna, Medical University Vienna, Austria
    • ,
  • Karin Dieckmann

      Affiliations

    • Department of Radiotherapy and Radiobiology, AKH Vienna, Medical University Vienna, Austria

Received 31 January 2008 ,Revised 11 June 2008 ,Accepted 19 June 2008.

References 

  1. Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol. 1993;21:172–181
  2. Pastore G, Znaor A, Spreafico F, Graf N, Pritchard-Jones K, Steliarova-Foucher E. Malignant renal tumours incidence and survival in European children (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2103–2114
  3. Ladenstein R, Philip T, Lasset C, et al. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry. J Clin Oncol. 1998;16:953–965
  4. Metzger ML, Dome JS. Current therapy for Wilms tumor. Oncologist. 2005;10:815–826
  5. Weirich A, Ludwig R, Graf N, et al. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Ann Oncol. 2004;15:808–820
  6. Wolden SL, Gollamudi SV, Kushner BH, et al. Local control with multimodality therapy for stage 4 neuroblastoma. Int J Radiat Oncol Biol Phys. 2000;46:969–974
  7. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3:203–216
  8. Dieckmann K, Widder J, Potter R. Long-term side effects of radiotherapy in survivors of childhood cancer. Front Radiat Ther Oncol. 2002;37:57–68
  9. de Graaf SS, van Gent H, Reitsma-Bierens WC, van Luyk WH, Dolsma WV, Postma A. Renal function after unilateral nephrectomy for Wilms’ tumour: the influence of radiation therapy. Eur J Cancer. 1996;32A:465–469
  10. Paulino AC, Wen BC, Brown CK, et al. Late effects in children treated with radiation therapy for Wilms’ tumor. Int J Radiat Oncol Biol Phys. 2000;46:1239–1246
  11. Potter R, Roes F, Schellong G, et al. Subclinical impairment of renal function after radiotherapy for Hodgkin’s disease in children. Recent Results Cancer Res. 1993;130:259–267
  12. Schwartz CL. Long-term survivors of childhood cancer: the late effects of therapy. Oncologist. 1999;4:45–54
  13. Bolsi A, Fogliata A, Cozzi L. Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: a treatment planning study. Radiother Oncol. 2003;68:1–14
  14. Cozzi L, Fogliata A, Lomax A, Bolsi A. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol. 2001;61:287–297
  15. Mock U, Bogner J, Georg D, Auberger T, Potter R. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Strahlenther Onkol. 2005;181:448–455
  16. Mock U, Georg D, Bogner J, Auberger T, Potter R. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:147–154
  17. Paulino AC, Ferenci MS, Chiang KY, Nowlan AW, Marcus RB. Comparison of conventional to intensity modulated radiation therapy for abdominal neuroblastoma. Pediatr Blood Cancer. 2006;46:739–744
  18. Miralbell R, Cella L, Weber D, Lomax A. Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams. Int J Radiat Oncol Biol Phys. 2000;47:1111–1119
  19. Schneider U, Lomax A, Lombriser N. Comparative treatment planning using secondary cancer mortality calculations. Phys Med. 2001;17(Suppl. 1):97–99
  20. Lomax AJ, Bohringer T, Bolsi A, et al. Treatment planning and verification of proton therapy using spot scanning: initial experiences. Med Phys. 2004;31:3150–3157
  21. Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol. 2006;80:263–267
  22. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65:1–7
  23. Hug EB, Nevinny-Stickel M, Fuss M, Miller DW, Schaefer RA, Slater JD. Conformal proton radiation treatment for retroperitoneal neuroblastoma: introduction of a novel technique. Med Pediatr Oncol. 2001;37:36–41
  24. Timmermann B, Schuck A, Niggli F, et al. Spot-scanning proton therapy for malignant soft tissue tumors in childhood: First experiences at the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys. 2007;67:497–504
  25. International Commission on Radiological Protection. ICRP Publication 50: Prescribing, recording and reporting photon beam therapy. Ann. ICRP. 1993.
  26. Miften M, Wiesmeyer M, Monthofer S, Krippner K. Implementation of FFT convolution and multirigid superposition models in the FOCUS RTP system. Phys Med Biol. 2000;45:817–833
  27. Soukup M, Fippel M, Alber M. A pencil beam algorithm for intensity modulated proton therapy derived from Monte Carlo simulations. Phys Med Biol. 2005;50:5089–5104
  28. Hong L, Goitein M, Bucciolini M, et al. A pencil beam algorithm for proton dose calculations. Phys Med Biol. 1996;41:1305–1330
  29. Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg. 2000;93(Suppl 3):219–222
  30. Dasu A, Toma-Dasu I, Olofsson J, Karlsson M. The use of risk estimation models for the induction of secondary cancers following radiotherapy. Acta Oncol. 2005;44:339–347
  31. International Commission on Radiological Protection. ICRP Publication 60. Ann ICRP. 1990.
  32. Dasu A, Toma-Dasu I. Dose–effect models for risk-relationship to cell survival parameters. Acta Oncol. 2005;44:829–835
  33. Steel G. Basic Clinical Radiobiology Hodder Arnold. 2002;
  34. Schneider U, Agosteo S, Pedroni E, Besserer J. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys. 2002;53:244–251
  35. Kry SF, Salehpour M, Followill DS, et al. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005;62:1204–1216
  36. Weber DC, Bogner J, Verwey J, et al. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: a comparative study. Int J Radiat Oncol Biol Phys. 2005;63:373–384
  37. Trofimov A, Nguyen PL, Coen JJ, et al. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison. Int J Radiat Oncol Biol Phys. 2007;69:444–453
  38. Taddei PJ, Fontenot JD, Yuanshui Z, et al. Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer. Phys Med Biol. 2008;53:2131–2147
  39. Rubino C, Adjadj E, Guerin S, et al. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment. Int J Cancer. 2003;107:791–796
  40. Carli M, Frascella E, Tournade MF, et al. Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1, 2, 5, and 6. Med Pediatr Oncol. 1997;29:239–244

☆ Hereby, we want to state that no actual or potential conflicts of interest exist.

PII: S0167-8140(08)00334-4

doi: 10.1016/j.radonc.2008.06.012

Radiotherapy & Oncology
Volume 89, Issue 2 , Pages 141-149 , November 2008

Article Tools

* Image Usage & Resolution